Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Consensus Recommendation of Moderate Buy from Analysts

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eight brokerages that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and six have given a buy recommendation to the […]

Related Keywords

United States ,Piper Sandler ,Perceptive Advisors ,Harmony Biosciences Holdings Inc ,Blackrock Inc ,Cantor Fitzgerald ,Goldman Sachs Group ,Needham Company ,Vanguard Group Inc ,Nasdaq ,Harmony Biosciences Holdings ,Get Free Report ,Harmony Biosciences ,Capital Partners ,Street Corp ,Get Free ,Biosciences Holdings ,Harmony Biosciences Daily ,Nasdaq Hrmy ,Thrmy ,Medical ,Ratings ,Consensus ,